PPARG and Alzheimer disease: Some potential strategies that may be used to target neuroinflammation in AD include (a) Peroxisome proliferator-activated receptor gamma (PPAR-γ) antagonists, which are drugs that activate a nuclear receptor that modulates inflammation and metabolism and may enhance the clearance of amyloid-β plaques and reduce the production of interleukins-1β.